Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick G Freitag

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Expert Review of Neurotherapeutics|May 12, 2007
Botulinum toxin type A in chronic migraineFrederick G Freitag
Psychopharmacology Bulletin|March 17, 2004
Divalproex in the treatment of migraineFrederick G Freitag
CNS Drugs|April 17, 2003
Preventative treatment for migraine and tension-type headaches : do drugs having effects on muscle spasm and tone have a role?Frederick G Freitag
Current Pain and Headache Reports|September 3, 2013
Why do migraines often decrease as we age?Frederick G Freitag
Frontiers in Pain Research (Lausanne, Switzerland)|March 17, 2022
Headache Medicine Grand Challenge: Headache: A New Frontier, A New ChallengeFrederick G Freitag
Clinical Therapeutics|August 19, 2007
The cycle of migraine: patients' quality of life during and between migraine attacksFrederick G Freitag
Expert Review of Neurotherapeutics|April 8, 2011
Sumatriptan needle-free subcutaneous (Sumavel(®) DosePro™) approved for the acute treatment of migraine, with or without aura, and cluster headachesFrederick G Freitag
Expert Review of Neurotherapeutics|March 2, 2010
Importance of botulinum toxin for prevention of migraineFrederick G Freitag
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Pharmacoeconomic benefits of almotriptan in the acute treatment of migraineFrederick G Freitag
The Lancet. Neurology|December 17, 2011
Headache: advances in understanding and treatmentFrederick G Freitag
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Expert Review of Neurotherapeutics|May 12, 2007
Botulinum toxin type A in chronic migraineFrederick G Freitag
Psychopharmacology Bulletin|March 17, 2004
Divalproex in the treatment of migraineFrederick G Freitag
CNS Drugs|April 17, 2003
Preventative treatment for migraine and tension-type headaches : do drugs having effects on muscle spasm and tone have a role?Frederick G Freitag
Current Pain and Headache Reports|September 3, 2013
Why do migraines often decrease as we age?Frederick G Freitag
Frontiers in Pain Research (Lausanne, Switzerland)|March 17, 2022
Headache Medicine Grand Challenge: Headache: A New Frontier, A New ChallengeFrederick G Freitag
Clinical Therapeutics|August 19, 2007
The cycle of migraine: patients' quality of life during and between migraine attacksFrederick G Freitag
Expert Review of Neurotherapeutics|April 8, 2011
Sumatriptan needle-free subcutaneous (Sumavel(®) DosePro™) approved for the acute treatment of migraine, with or without aura, and cluster headachesFrederick G Freitag
Expert Review of Neurotherapeutics|March 2, 2010
Importance of botulinum toxin for prevention of migraineFrederick G Freitag
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Pharmacoeconomic benefits of almotriptan in the acute treatment of migraineFrederick G Freitag
The Lancet. Neurology|December 17, 2011
Headache: advances in understanding and treatmentFrederick G Freitag
Pageof 3